EurekAlert!

Early IABP use no better than medication in cardiogenic shock due to heart failure

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
News Medical

Study finds no benefit of early IABP use in cardiogenic shock patients

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
TCTMD

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Hemodynamic support reduces 6-month mortality in patients with large ST-segment elevation myocardial infarction (STEMI) complicated by persistent ischemia after percutaneous coronary intervention (PCI ...
Medscape

The Intra-aortic Balloon Pump in High-risk Percutaneous Coronary Intervention

The applicability and validity of registry data remains open to debate. When studying a patient cohort that is notoriously difficult to enroll in randomized trials, registry data can certainly add ...
Medscape

Intra-aortic Balloon Pump May Best Inotropes in Decompensated HF

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...
TCTMD

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

Continuing the trajectory seen at 30 days and 1 year, the long-term data from the IABP-SHOCK II trial reported today show no survival benefit for intra-aortic balloon pump (IABP) use in acute MI ...
News Medical

Intra-aortic balloon pump support reduces 30-day mortality in postinfarction VSR patients

Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...
MedPage Today

Runners' Cardiac Toll Down; IABP Flop in Cardiogenic Shock; Progress on Oral PCSK9i

Compared with the years 2000-2009, cardiac deaths and case fatalities in U.S. marathon and half-marathon runners have come down significantly. (JAMA) People with zero of five classic cardiovascular ...
Business Insider

Angiodroid Srl Announces CE Mark for ANGIOPULSE™ Intra-aortic Balloon Pump

ANGIODROID Srl, an Italian manufacturer of medical technologies, announces the CE mark for ANGIOPULSE, its first intra-aortic balloon pump (IABP) device. (Photo ...
Nature

Extended follow-up in IABP-SHOCK II shows no reduction in all-cause mortality with IABP

In the multicentre, open-label, randomized, controlled trial IABP-SHOCK II, the previously reported 30-day data demonstrated no early mortality reduction with intra-aortic balloon pump (IABP) use in ...
MedPage Today

Pilot Study Hints at IABP Benefit for Some STEMI Patients

PARIS -- Intra-aortic balloon pumps (IABP) didn't significantly improve outcomes for patients with ischemia persisting well after percutaneous coronary intervention (PCI) for a large acute ST-segment ...